Monthly revenue and year-on-year change for CPE (1215) and GeneFerm Biotechnology (1796) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.
Year-on-year change
Monthly revenue history
| Month | CPE | YoY | GeneFerm Biotechnology | YoY |
|---|---|---|---|---|
| Oct 2026 | NT$2.66 billion | +13.4% | NT$58.5 million | +0.1% |
| Sep 2026 | NT$2.54 billion | +6.2% | NT$48.2 million | -12.4% |
| Aug 2026 | NT$2.36 billion | +1.3% | NT$57.3 million | -10.9% |
| Jul 2026 | NT$2.56 billion | +8.1% | NT$64.6 million | +39.8% |
| Jun 2026 | NT$2.42 billion | +8.7% | NT$70.6 million | +22.8% |
| May 2026 | NT$2.49 billion | +1.7% | NT$46.9 million | -8.9% |
| Apr 2026 | NT$2.32 billion | -2.9% | NT$51.4 million | -12.6% |
| Mar 2026 | NT$2.51 billion | +7.5% | NT$52.8 million | -12.9% |
| Feb 2026 | NT$2.03 billion | +0.0% | NT$46 million | +2.7% |
| Jan 2026 | NT$2.63 billion | +13.0% | NT$54.4 million | -10.8% |
| Dec 2025 | NT$2.75 billion | +13.0% | NT$61.9 million | +11.6% |
| Nov 2025 | NT$2.48 billion | +1.9% | NT$56.9 million | +19.7% |
| Oct 2025 | NT$2.35 billion | -4.5% | NT$58.5 million | +12.4% |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16